yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42332335-E75BDCCF-3E7D-42ED-A88F-526E794D69D4
Q42332335-E75BDCCF-3E7D-42ED-A88F-526E794D69D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42332335-E75BDCCF-3E7D-42ED-A88F-526E794D69D4
Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
P2860
Q42332335-E75BDCCF-3E7D-42ED-A88F-526E794D69D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42332335-E75BDCCF-3E7D-42ED-A88F-526E794D69D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70c49f3db5d4d9ac9c8b73a32f2aa6a03ae65575
P2860
Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review.